Condensed Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2017	Sep. 30, 2016	Sep. 29, 2017	Sep. 30, 2016
Net sales	$ 793.9	$ 887.2	$ 2,429.3	$ 2,569.6
Cost of sales	393.3	397.0	1,194.0	1,165.5
Gross profit	400.6	490.2	1,235.3	1,404.1
Selling, general and administrative expenses	205.7	267.8	745.9	702.0
Research and development expenses	59.5	67.9	190.9	200.8
Restructuring charges, net	14.3	6.8	32.1	29.2
Non-restructuring impairment charges	0.0	0.0	0.0	16.9
Losses (gains) on divestiture and license	0.4	0.0	(56.6)	0.0
Operating income	120.7	147.7	323.0	455.2
Interest expense	(92.6)	(94.0)	(279.0)	(286.8)
Interest income	1.3	0.5	2.8	1.1
Other income (expense), net	3.7	(0.6)	6.2	(2.6)
Income from continuing operations before income taxes	33.1	53.6	53.0	166.9
Income tax benefit	(31.2)	(56.4)	(110.8)	(218.3)
Income from continuing operations	64.3	110.0	163.8	385.2
(Loss) income from discontinued operations, net of income taxes	(0.6)	5.0	361.9	47.4
Net income	$ 63.7	$ 115.0	$ 525.7	$ 432.6
Basic earnings per share (Note 7):
Income from continuing operations, per share	$ 0.66	$ 1.02	$ 1.65	$ 3.53
(Loss) income from discontinued operations, per share	(0.01)	0.05	3.64	0.43
Net income, per share	$ 0.66	$ 1.07	$ 5.28	$ 3.97
Basic weighted-averaged shares outstanding (in shares)	96.7	107.6	99.5	109.1
Diluted earnings per share (Note 7):
Income from continuing operations, per share	$ 0.66	$ 1.01	$ 1.64	$ 3.50
(Loss) income from discontinued operations, per share	(0.01)	0.05	3.63	0.43
Net income, per share	$ 0.66	$ 1.06	$ 5.27	$ 3.93
Diluted weighted-average shares outstanding (in shares)	97.0	108.6	99.8	110.0